Linking radiosilver to monoclonal antibodies reduced by ascorbic acia D. K. HazraV. L. LahiriShabd Saran OriginalPaper Pages: 1 - 7
Removal of endotoxin from antibody preparations for clinical use V. L. LahiriR. K. SrivastavaManish Pathak OriginalPaper Pages: 9 - 14
Potent antitumor effects of an antitumor endothelial cell immunotoxin in a murine vascular targeting model Francis J. BurrowsJay P. OverholserPhilip E. Thorpe OriginalPaper Pages: 15 - 25
Glioblastoma therapy by direct intralesional administration of I-131 radioiodine labeled antitenascin antibodies P. RivaA. AristaN. Riva OriginalPaper Pages: 37 - 43
Mechanisms in removal of tumor by antibody G. T. StevensonA. J. BellG. M. Mead OriginalPaper Pages: 45 - 50
Fusion protein mediated prodrug activation (FMPA) in vivo K. BossletJ. CzechD. Hoffmann OriginalPaper Pages: 51 - 63
Both VH and VL regions contribute to the antigenicity of anti-idiotypic antibody that mimics melanoma associated ganglioside GM3 Shinji KandaHiromitsu TakeyamaReiko F. Irie OriginalPaper Pages: 65 - 74
Immunotargeting of urothelial cell carcinoma with intravesically administered Tc-99m labeled HMFG1 monoclonal antibody J. MalamitsiJ. ZorzosCh. Proukakis OriginalPaper Pages: 75 - 81
Clinical radioimmunolocalization with a rat monoclonal antibody directed against c-erbB-2 S. M. AllanC. J. DeanN. P. M. Sacks OriginalPaper Pages: 93 - 98
Use of technetium antigranulocyte monoclonal antibody Fab' fragments for the detection of osteomyelitis S. J. HarwoodJ. G. CamblinR. G. Carroll OriginalPaper Pages: 99 - 107
Biosensor analysis of antigen-antibody interactions as a priority step in the generation of monoclonal bispecific antibodies Alberto HorensteinClaudio PoiesiFabio Malavasi OriginalPaper Pages: 109 - 117
Effect of a bifunctional monoclonal antibody directed against a tumor marker and doxorubicin on the growth of epidermoid vulvar carcinoma grafted in athymic mice D. MorelliS. MénardM. I. Colnaghi OriginalPaper Pages: 119 - 126
Conjugates of COL-1 monoclonal antibody and β-D-galactosidase can specifically kill tumor cells by generation of 5-fluorouridine from the prodrug β-D-galactosyl-5-fluorouridine Ralph AbrahamNureddin AmanRichard Titmas OriginalPaper Pages: 127 - 133
Complete ablation of small squamous cell carcinoma xenografts with186Re-labeled monoclonal antibody E48 Martijn GerretsenGerard W. M. VisserGuus A. M. S. van Dongen OriginalPaper Pages: 135 - 142
Anti-idotype and recombinant antigen in immunotherapy of colorectal cancer D. HerlynR. SomasundaramM. Mastrangelo OriginalPaper Pages: 143 - 153
Preclinical studies of monoclonal antibodies for intravesical radioimmunotherapy of human bladder cancer Pamela J. RussellKaryn DavisNicholas Pearce OriginalPaper Pages: 155 - 161
In vitro activity of immunoconjugates between cisplatin and an anti-CA125 monoclonal antibody on ovarian cancer cell lines E. BeckM. HofmannN. Lang OriginalPaper Pages: 163 - 173
Comparison of the cellular internalization of antibodies used either as immunotoxins or in ADEPT D. C. BlakeyP. E. PinderA. F. Wright OriginalPaper Pages: 175 - 183
Comparison of two anthracycline-based prodrugs for activation by a monoclonal antibody-β-glucuronidase conjugate in the specific treatment of cancer H. J. HaismaM. van MuijenE. Boven OriginalPaper Pages: 185 - 192
Analysis of antibody-enzyme conjugate clearance by investigation of prodrug and active drug in an ADEPT clinical study C. J. SpringerG. K. PoonK. D. Bagshawe OriginalPaper Pages: 193 - 207
Biological studies and potential therapeutic applications of monoclonal antibodies and small molecules reactive with theneu/c-erbB-2 protein William C. DougallMark I. Greene OriginalPaper Pages: 209 - 218
Antibody-directed enzyme prodrug therapy (ADEPT) Surinder K. SharmaJoan A. BodenKenneth D. Bagshawe OriginalPaper Pages: 219 - 228
Functional expression in mast cells of chimeric receptors with antibody specificity Nathan L. BachTova WaksZelig Eshhar OriginalPaper Pages: 229 - 236
Monoclonal antibodies and idiotypic network activation for ovarian carcinoma U. WagnerJ. ReinsbergD. Krebs OriginalPaper Pages: 237 - 242
Deoxyribonuclease I (DNase I) H. LinardouM. P. DeonarainA. A. Epenetos OriginalPaper Pages: 243 - 248
Targeting phosphodiesterases as a strategy for killing tumor cells Mahendra P. DeonarainAgamemnon A. Epenetos OriginalPaper Pages: 249 - 257
Idiotypic cascades after injection of the monoclonal antibody OC125 B. C. SchultesJ. ReinsbergH. J. Biersack OriginalPaper Pages: 259 - 266
Tumor targeting in a murine tumor xenograft model with the (sFv′)2 divalent form of anti-c-erbB-2 single-chain Fv James S. HustonGregory P. AdamsLouis M. Weiner OriginalPaper Pages: 267 - 278
Preclinical models for the evaluation of targeted therapies of metastatic disease S. A. EcclesG. BoxC. J. Dean OriginalPaper Pages: 279 - 291
Correlation of beta-camera imaging and immunohistochemistry in radioimmunotherapy using90Y-labeled monoclonal antibodies in ovarian cancer animal models Kalevi J. A. KairemoKaj LjunggrenSven-Erik Strand OriginalPaper Pages: 293 - 300
Study of peripheral blood lymphocyte subset distribution and IL-2 receptor (IL-2 R) p55–p75 subunit expression in patients with cancer of different sites G. MantovaniA. MacciòG. S. Del Giacco OriginalPaper Pages: 301 - 305
Combined use of111In-labeled pentetreotide and three-step immunoscintigraphy with antichromogranin a monoclonal antibody in the diagnosis of pituitary adenomas P. MagnaniG. PaganelliF. Fazio OriginalPaper Pages: 307 - 313
Immunotoxin studies in a model of human T-cell acute lymphoblastic leukemia developed in severe combined immune-deficient mice B. J. MorlandD. BoehmD. J. Flavell OriginalPaper Pages: 315 - 329
Sequencing data of the antiglioma antibody MUC 2-63 and strategy for construction of chimeric antibodies C. HagelM. NeumaierD. Stavrou OriginalPaper Pages: 331 - 339